Generic Labeling Problems Targeted In US FDA Budget Request
Executive Summary
Agency seeks legislative authority to update outdated generic drug labels when the reference product has been withdrawn.
You may also be interested in...
FDA Review Modernization Fully Funded
After receiving $25.1m in FY 2019, Congress gave another $1.9m in FY 2020, which appropriators said combined reaches the $27m requested for the FY 2020 budget.
Generics Modernization Effort At US FDA Receives Full Funding Over Two Years
After receiving $25.1m in FY 2019, Congress gave another $1.9m in FY 2020, which appropriators said combined reaches the $27m requested for the FY 2020 budget.
Senate Bill Would Prevent Safety Label Carve-Outs From Delaying Approvals
Updated drug pricing bill would allow US FDA to approve generics even if innovator safety information is protected by exclusivity.